earnings
SE
NASDAQ · SERA
Sera Prognostics, Inc.
Healthcare · Medical - Diagnostics & Research
$2.14
Up+$0.04 (+1.90%)
Updated Aug 23, 2026, 8:29 PM
SID Score
5.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 127.56M
- P/E ratio
- -5.15
- Dividend yield
- 0.00%
- 52-week range
- $1.56 – $2.46
- Volume
- 14.57K
- Avg. volume
- 44.27K
Price performance
SERA price history
1M range · 20 trading sessions · Daily adjusted prices
SERA closed at $2.14 after 20 trading sessions, up 4.39% for the selected period.
- Last close
- $2.14
- Period change
- +4.39%
- Period low
- $1.93
- Period high
- $2.14
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | $2.09 | $2.16 | $2.085 | $2.14 | 14.57K |
| Aug 20, 2026 | $1.99 | $2.10 | $1.99 | $2.10 | 30.86K |
| Aug 19, 2026 | $2.04 | $2.05 | $1.9801 | $1.99 | 26.26K |
| Aug 18, 2026 | $2.00 | $2.00 | $1.915 | $1.93 | 9.49K |
| Aug 17, 2026 | $1.94 | $2.025 | $1.94 | $1.95 | 26.94K |
| Aug 14, 2026 | $2.01 | $2.05 | $1.96 | $1.96 | 13.53K |
| Aug 13, 2026 | $2.03 | $2.07 | $1.9101 | $2.01 | 35.8K |
| Aug 12, 2026 | $2.00 | $2.05 | $1.97 | $2.02 | 27.69K |
| Aug 11, 2026 | $1.89 | $2.06 | $1.89 | $1.99 | 39.52K |
| Aug 10, 2026 | $2.05 | $2.05 | $1.935 | $2.01 | 30.86K |
| Aug 7, 2026 | $2.00 | $2.20 | $1.8514 | $2.07 | 61.38K |
| Aug 6, 2026 | $1.99 | $2.00 | $1.935 | $2.00 | 16.84K |
| Aug 5, 2026 | $1.91 | $2.01 | $1.89 | $2.00 | 58K |
| Aug 4, 2026 | $2.09 | $2.15 | $1.93 | $1.93 | 87.17K |
| Aug 3, 2026 | $1.98 | $2.1885 | $1.98 | $2.10 | 15.27K |
| Jul 31, 2026 | $2.09 | $2.13 | $2.01 | $2.04 | 24.66K |
| Jul 30, 2026 | $2.06 | $2.1782 | $1.97 | $2.10 | 79.02K |
| Jul 29, 2026 | $2.01 | $2.1446 | $2.01 | $2.05 | 11.19K |
| Jul 28, 2026 | $2.05 | $2.05 | $1.98 | $2.03 | 26.13K |
| Jul 27, 2026 | $2.05 | $2.21 | $1.95 | $2.05 | 76.83K |
Latest SERA news
The latest Smart Investors Daily articles mentioning SERA.
Stock researchResearch & News · SEC Filings
Loading stock research…